Coherus Oncology Inc (CHRS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 115,238 | 88,879 | 103,352 | 216,893 | 82,411 |
| Marketable Securities | 51,810 | 83,246 | 88,311 | 20,744 | N/A |
| Receivables | 22,510 | 18,418 | 250,496 | 119,639 | 62,436 |
| Inventories | 4,825 | 3,172 | 2,048 | 4,513 | 3,518 |
| Other current assets | 9,379 | 6,233 | 8,700 | 11,716 | 154,902 |
| TOTAL | $206,035 | $206,706 | $460,955 | $380,205 | $310,175 |
| Non-Current Assets | |||||
| PPE Net | 1,094 | 1,345 | 1,633 | 1,907 | 2,256 |
| Intangibles | 45,614 | 46,239 | 49,484 | 52,312 | 52,979 |
| Other Non-Current Assets | 13,279 | 4,053 | 4,447 | 5,040 | 5,656 |
| TOTAL | $59,987 | $51,637 | $55,564 | $59,259 | $60,891 |
| Total Assets | $266,022 | $258,343 | $516,519 | $439,464 | $371,066 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 11,479 | 9,915 | 24,893 | 37,622 | 40,930 |
| Accrued Expenses | 120,853 | 130,471 | 347,404 | 226,007 | 214,112 |
| TOTAL | $132,332 | $140,386 | $372,297 | $263,629 | $255,042 |
| Non-Current Liabilities | |||||
| Long Term Debt | 37,147 | 37,051 | 36,957 | 36,867 | 36,781 |
| Other Non-Current Liabilities | 17,920 | 19,892 | 19,491 | 19,141 | 262,713 |
| TOTAL | $55,067 | $56,943 | $56,448 | $56,008 | $299,494 |
| Total Liabilities | $187,399 | $197,329 | $428,745 | $319,637 | $554,536 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 154,250 | 149,890 | 120,871 | 116,227 | 115,933 |
| Common Shares | 15 | 12 | 12 | 12 | 12 |
| Retained earnings | -1,421,296 | -1,382,969 | -1,345,326 | -1,309,795 | -1,607,562 |
| Other shareholders' equity | -268 | -195 | -203 | -275 | -275 |
| TOTAL | $78,623 | $61,014 | $87,774 | $119,827 | $-183,470 |
| Total Liabilities And Equity | $266,022 | $258,343 | $516,519 | $439,464 | $371,066 |